https://www.nasuspharma.com/nasus-pharma-announces-publication-of-its-positive-clinical-results-with-fmxin002-intranasal-powder-epinephrine-spray-in-the-journal-of-allergy-and-clinical-immunology-in-practice/?utm_source=rss&utm_medium=rss&utm_campaign=nasus-pharma-announces-publication-of-its-positive-clinical-results-with-fmxin002-intranasal-powder-epinephrine-spray-in-the-journal-of-allergy-and-clinical-immunology-in-practice New frontier in Intranasal drug delivery Mon, 13 Nov 2023 10:03:37 +0000 hourly 1 https://wordpress.org/?v=6.5.3